REVIVA PHARMACEUTICALS HOLDINGS, INC. — Form D
REVIVA PHARMACEUTICALS HOLDINGS, INC. of CUPERTINO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-19. Industry: Pharmaceuticals.
Offering
- Filed: 2022-09-19
- Form: D
- Accession: 0001493152-22-026229
- Industry: Pharmaceuticals
- Exemptions: 06b
- Investors: 3
- Date of first sale: 2022-09-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-459214
Issuer
- Name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK: 0001742927
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 19925 STEVENS CREEK BLVD., CUPERTINO, CA, 95014
- Phone: (408) 501-8881
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Laxminarayan Bhat | Director | SAN JOSE, CA |
| Les Funtleyder | Director | New York, NY |
| Richard Margolin | Director | Cupertino, CA |
| Purav Patel | Director | Cupertino, CA |
| Parag Saxena | Director | New York, NY |
| Laxminarayan Bhat | Executive Officer | SAN JOSE, CA |
| Narayan Prabhu | Executive Officer | Cupertino, CA |
More